1. On ethics: Dr. Margaret Chan, director general of the WHO, criticized the pharmaceutical industry for being "profit driven" and for failing to invest in the development of a vaccine or cure for Ebola. As CEO of a leading pharmaceutical firm, how do you respond to these criticisms?
2) On Ethics: As a shareholder of a pharmaceutical firm that announced its new investment to develop an Ebola vaccine and that as a result, your dividend would be reduced, would you support or not support the firms decision to spend your money to combat Ebola?
3) On Ethics: As a government official, what would be your recommendations to incentivize pharmaceutical firms to develop an Ebola vaccine?